Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 28, 2006
A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKDGerald Schulman, Rajiv Agarwal, Muralidhar Acharya, et al.
Biochimica Et Biophysica Acta|January 27, 2004
Phosphorylation of MAP kinase-like proteins mediate the response of the halotolerant alga Dunaliella viridis to hypertonic shockCarlos Jiménez, Tomas Berl, Christopher J Rivard, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2008
Hypertonic stress increases claudin-4 expression and tight junction integrity in association with MUPP1 in IMCD3 cellsMiguel A Lanaspa, Ana Andres-Hernando, Christopher J Rivard, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 29, 2007
Long-term outcomes after coronary artery bypass grafting: preoperative kidney function is prognosticMichel B Chonchol, Victor Aboyans, Philippe Lacroix, et al.
The Journal of Biological Chemistry|May 9, 2009
ZAC1 is up-regulated by hypertonicity and decreases sorbitol dehydrogenase expression, allowing accumulation of sorbitol in kidney cellsMiguel A Lanaspa, Ana Andres-Hernando, Christopher J Rivard, et al.
European Journal of Endocrinology|February 15, 2011
Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretionJoseph G Verbalis, Suzanne Adler, Robert W Schrier, et al.
The New England Journal of Medicine|November 16, 2006
Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremiaRobert W Schrier, Peter Gross, Mihai Gheorghiade, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 11, 2007
The tight junction protein, MUPP1, is up-regulated by hypertonicity and is important in the osmotic stress response in kidney cellsMiguel A Lanaspa, Nestor E Almeida, Ana Andres-Hernando, et al.
Journal of the American Society of Nephrology : JASN|October 29, 2014
Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKDGerald Schulman, Tomas Berl, Gerald J Beck, et al.
Clinical and Experimental Nephrology|July 26, 2017
Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120Gerald Schulman, Tomas Berl, Gerald J Beck, et al.
Pageof 6